Tango Therapeutics Inc (TNGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2009 | 12-2008 | 12-2007 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 6,163 | 6,554 | N/A |
| Receivables | 11,517 | 11,384 | N/A |
| TOTAL | $19,265 | $18,808 | $N/A |
| Non-Current Assets | |||
| PPE Net | 1,761 | 1,625 | N/A |
| Intangibles | 34,478 | 32,613 | 0 |
| Other Non-Current Assets | 573 | 1,828 | 0 |
| TOTAL | $36,813 | $36,066 | $N/A |
| Total Assets | $56,078 | $54,874 | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 2,858 | 2,745 | 0 |
| Accrued Expenses | 2,285 | 2,802 | N/A |
| Other current liabilities | 200 | 200 | N/A |
| TOTAL | $21,622 | $19,296 | $N/A |
| Non-Current Liabilities | |||
| Long Term Debt | 11,933 | 15,408 | N/A |
| Deferred Revenues | 6,881 | 6,940 | N/A |
| Other Non-Current Liabilities | 58,116 | 54,354 | 0 |
| TOTAL | $73,488 | $71,060 | $N/A |
| Total Liabilities | $95,110 | $90,356 | $N/A |
| Shareholders' Equity | |||
| Common Shares | 2 | 2 | N/A |
| Retained earnings | -46,104 | -39,772 | N/A |
| Other shareholders' equity | 1,973 | -72 | 0 |
| TOTAL | $-39,032 | $-35,482 | $N/A |
| Total Liabilities And Equity | $56,078 | $54,874 | $0 |